P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Other Long-Term Assets
â‚©9.8B
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Other Long-Term Assets
â‚©143.9B
CAGR 3-Years
36%
CAGR 5-Years
26%
CAGR 10-Years
21%
SK Bioscience Co Ltd
KRX:302440
Other Long-Term Assets
â‚©88.3B
CAGR 3-Years
62%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Other Long-Term Assets
â‚©69.5B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
24%
H
Hugel Inc
KOSDAQ:145020
Other Long-Term Assets
â‚©31.1B
CAGR 3-Years
39%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Other Long-Term Assets
â‚©2.7B
CAGR 3-Years
417%
CAGR 5-Years
45%
CAGR 10-Years
N/A
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P

See Also

What is PharmaResearch Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
9.8B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Other Long-Term Assets amounts to 9.8B KRW.

What is PharmaResearch Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
23%

Over the last year, the Other Long-Term Assets growth was 10%. The average annual Other Long-Term Assets growth rates for PharmaResearch Co Ltd have been 28% over the past three years , 23% over the past five years .

Back to Top